Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...

Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its workforce by "approximately" 20% ...

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today reported financial results for the year and quarter ...

Manufactured by local maritime start-up Pyxis, these new solar-powered river boats named Pyxis R ferries will replace half of river cruise operator WaterB’s fleet of 20 boats by the end of 2025.

Greece’s Pyxis Tankers plans to take advantage of falling vessel values to grow the fleet in the near future. The Nasdaq-listed company earned a fourth-quarter profit in deteriorating market ...